Epidemiology and Staging of Renal Cell Carcinoma

Carole A. Ridge; Bradley B. Pua; David C. Madoff

doi:10.1055/s-0033-1363837

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2014; 31(01): 003-008
DOI: 10.1055/s-0033-1363837

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Epidemiology and Staging of Renal Cell Carcinoma

Authors

Carole A. Ridge

¹Department of Radiology, Mater Misericordiae University Hospital, Dublin, Ireland
Bradley B. Pua

²Division of Interventional Radiology, Department of Radiology, New York–Presbyterian Hospital/Weill Cornell Medical College, New York, New York
David C. Madoff

²Division of Interventional Radiology, Department of Radiology, New York–Presbyterian Hospital/Weill Cornell Medical College, New York, New York

Abstract

Incidence and mortality trends attributed to kidney cancer exhibit marked regional variability, likely related to demographic, environmental, and genetic factors. Efforts to identify reversible factors, which lead to the development of renal cell carcinoma (RCC), have led not only to a greater understanding of the etiology of RCC but also the genetic and histologic characteristics of renal tumors. This article describes this evolution by discussing contemporary RCC incidence and mortality data, the risk factors for development of RCC, the histologic features, and anatomic and integrated staging systems that guide treatment.

Keywords

renal cell carcinoma - kidney cancer - epidemiology and staging - incidence - mortality - risk factors

Full Text

References

References
1 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127 (12) 2893-2917
2 Ljungberg B, Campbell SC, Choi HY , et al. The epidemiology of renal cell carcinoma. Eur Urol 2011; 60 (4) 615-621
3 Howlader N, Noone AM, Krapcho M , et al, (eds). SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/ , based on November 2012 SEER data submission, posted to the SEER web site, April 2013
4 Levi F, Ferlay J, Galeone C , et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 2008; 101 (8) 949-958
5 Chow WH, Linehan WM, Devesa SS. Re: Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2007; 99 (7) 569-570 , author reply 570–571
6 Chow WH, Devesa SS. Contemporary epidemiology of renal cell cancer. Cancer J 2008; 14 (5) 288-301
7 Berndt SI, Carter HB, Schoenberg MP, Newschaffer CJ. Disparities in treatment and outcome for renal cell cancer among older black and white patients. J Clin Oncol 2007; 25 (24) 3589-3595
8 Becker A, Roghmann F, Trinh QD , et al. Sociodemographic disparities in the treatment of small renal masses. BJU Int 2013; 111 (8) E274-E282
9 Rampersaud EN, Klatte T, Bass G , et al. The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma. Urol Oncol 2014; 32 (1) 30
10 Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010; 7 (5) 245-257
11 Tsivian M, Moreira DM, Caso JR, Mouraviev V, Polascik TJ. Cigarette smoking is associated with advanced renal cell carcinoma. J Clin Oncol 2011; 29 (15) 2027-2031
12 Orth SR. Cigarette smoking: an important renal risk factor—far beyond carcinogenesis. Tob Induc Dis 2002; 1 (2) 137-155
13 Clague J, Shao L, Lin J , et al. Sensitivity to NNKOAc is associated with renal cancer risk. Carcinogenesis 2009; 30 (4) 706-710
14 Zhu Y, Horikawa Y, Yang H, Wood CG, Habuchi T, Wu X. BPDE induced lymphocytic chromosome 3p deletions may predict renal cell carcinoma risk. J Urol 2008; 179 (6) 2416-2421
15 Macleod LC, Hotaling JM, Wright JL , et al. Risk Factors for Renal Cell Carcinoma in the Vitamin and Lifestyle (VITAL) Study. J Urol 2013; 190 (5) 1657-1661
16 Häggström C, Rapp K, Stocks T , et al. Metabolic factors associated with risk of renal cell carcinoma. PLoS ONE 2013; 8 (2) e57475
17 Colt JS, Schwartz K, Graubard BI , et al. Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology 2011; 22 (6) 797-804
18 Chauveau D, Duvic C, Chrétien Y , et al. Renal involvement in von Hippel-Lindau disease. Kidney Int 1996; 50 (3) 944-951
19 Pfaffenroth EC, Linehan WM. Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy. Expert Opin Biol Ther 2008; 8 (6) 779-790
20 Tomlinson IP, Alam NA, Rowan AJ , et al; Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002; 30 (4) 406-410
21 Northrup BE, Jokerst CE, Grubb III RL, Menias CO, Khanna G, Siegel CL. Hereditary renal tumor syndromes: imaging findings and management strategies. AJR Am J Roentgenol 2012; 199 (6) 1294-1304
22 Cohen D, Zhou M. Molecular genetics of familial renal cell carcinoma syndromes. Clin Lab Med 2005; 25 (2) 259-277
23 Sheth S, Scatarige JC, Horton KM, Corl FM, Fishman EK. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT. Radiographics 2001; 21 (Spec No): S237-S254
24 Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer Science and Business Media; 2010
25 Cho MC, Kim JK, Moon KC, Kim HH, Kwak C. Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system. Int Braz J Urol 2013; 39 (3) 353-363
26 Ljungberg B, Cowan NC, Hanbury DC , et al; European Association of Urology Guideline Group. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010; 58 (3) 398-406
27 Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2004: 7
28 Pignot G, Elie C, Conquy S , et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 2007; 69 (2) 230-235
29 Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6 (7) 655-663
30 Kontak JA, Campbell SC. Prognostic factors in renal cell carcinoma. Urol Clin North Am 2003; 30 (3) 467-480
31 Meskawi M, Sun M, Trinh QD , et al. A review of integrated staging systems for renal cell carcinoma. Eur Urol 2012; 62 (2) 303-314
32 Zisman A, Pantuck AJ, Dorey F , et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 2001; 19 (6) 1649-1657
33 Zisman A, Pantuck AJ, Wieder J , et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002; 20 (23) 4559-4566